---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-005030"
form_type: "8-K"
ticker: "NVNO"
cik: "0001661053"
company_name: "enVVeno Medical Corp"
filed_at: "2026-02-04T23:59:59+00:00"
generated_at: "2026-05-16T04:57:04.876060+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# enVVeno Medical regains Nasdaq minimum bid price compliance; reports $28M cash at year-end

## Summary
- Received formal Nasdaq notice confirming compliance with minimum bid price rule; closing bid ≥ $1.00 for 10 consecutive business days Jan 20 - Feb 2, 2026, matter closed.
- Cash and investments balance approximately $28 million as of December 31, 2025.
- Company expects to share additional details on 2026 strategic plans in coming weeks; believes it is well-positioned for 2026.

## SEC filing metadata
- accession: 0001493152-26-005030
- form_type: 8-K
- ticker: NVNO
- cik: 0001661053
- company_name: enVVeno Medical Corp
- filed_at: 2026-02-04T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661053/000149315226005030/0001493152-26-005030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661053/000149315226005030/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-005030
- JSON: https://secwatch.observer/filing/0001493152-26-005030.json
- Plain text: https://secwatch.observer/filing/0001493152-26-005030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.